Accelerating HPV Therapeutic Development: Jeeva’s Role in FVT’s Phase II Clinical Trials

Explore how Frantz Viral Therapeutics uses Jeeva’s electronic data capture (EDC) platform to support ongoing Phase II trials for HPV-related precancerous conditions, including anal (AIN), vulvar (VIN), and cervical (CIN) intraepithelial neoplasia, with a focus on efficient clinical data management and regulatory requirements.

Integrated EDC

Regulatory-Ready Data

Cost-Efficient Trial Execution

CASE STUDY

Frantz Viral Therapeutics

Accelerating HPV Therapeutic Development: Jeeva’s Role in FVT’s Phase II Clinical Trials

Jeeva Clinical Trials Inc.

What’s inside this case study?

Discover a More Efficient Approach to Clinical Data Management

Learn how Jeeva supports ongoing HPV clinical trials through streamlined electronic data capture, regulatory-ready data management, and cost-conscious trial operations without the need for extensive in-house IT infrastructure.

Data management challenges in Phase II clinical trials

Supporting multiple HPV-related indications through EDC

Regulatory requirements for clinical data capture and storage

Jeeva’s role in cost-conscious trial operations

I appreciate the functionality of the system. The Jeeva team has been helpful in working with us to provide exactly what we needed for our pivotal study.

Frantz Viral Therapeutics

Download the Case Study

Discover how Jeeva supports efficient, regulatory-ready clinical data management for ongoing HPV therapeutic development. Complete the form to access the full case study.

By submitting, you agree that we may process your details for this request as described in our Privacy Policy.